Talk to More Primary Prevention Patients About the Benefits and Risks of Statins

May 2016

More patients will take statins for PRIMARY prevention of CV disease.

We know statins improve outcomes for SECONDARY prevention. But what about patients who DON'T have CV disease?

Up until now, evidence has been murkier...especially in nonwhites.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote